Changes in systemic vascular endothelial growth factor levels after intravitreal injection of aflibercept in infants with retinopathy of prematurity

被引：0
|
作者：
Chung-Ying Huang
Reyin Lien
Nan-Kai Wang
An-Ning Chao
Kuan-Jen Chen
Tun-Lu Chen
Yih-Shiou Hwang
Chi-Chun Lai
Wei-Chi Wu
机构：
[1] Chang Gung Memorial Hospital,Department of Ophthalmology
[2] College of Medicine,Chang Gung University
[3] Chang Gung Memorial Hospital,Department of Pediatrics
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2018年 / 256卷
关键词：
Intravitreal injection of aflibercept; Intravitreal injection of bevacizumab; Retinopathy of prematurity; Vascular endothelial growth factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：479 / 487
页数：8
相关论文
共 50 条
  • [31] Treatment for Nontype 1 Retinopathy of Prematurity by Intravitreal Injection of Antivascular Endothelial Growth Factor Drugs
    Zhang, Haitao
    Yang, Xin
    Zheng, Fangfang
    Yin, Xiangke
    Wan, Suhua
    JOURNAL OF OPHTHALMOLOGY, 2022, 2022
  • [32] Vitreous Levels of Erythropoietin and Vascular Endothelial Growth Factor in Eyes with Retinopathy of Prematurity
    Sato, Tatsuhiko
    Kusaka, Shunji
    Shimojo, Hiroshi
    Fujikado, Takashi
    OPHTHALMOLOGY, 2009, 116 (09) : 1599 - 1603
  • [33] Systemic levels of vascular endothelial growth factor before and after intravitreal injection of aflibercept or ranibizumab in patients with age-related macular degeneration: a randomised, prospective trial
    Zehetner, Claus
    Kralinger, Martina T.
    Modi, Yasha S.
    Waltl, Inga
    Ulmer, Hanno
    Kirchmair, Rudolf
    Bechrakis, Nikolaos E.
    Kieselbach, Gerhard F.
    ACTA OPHTHALMOLOGICA, 2015, 93 (02) : E154 - E159
  • [34] ENDOPHTHALMITIS AFTER INTRAVITREAL VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTION FOR DIABETIC MACULAR EDEMA AND DIABETIC RETINOPATHY
    Thinggaard, B. S.
    Pedersen, F. P.
    Subhi, Y. S.
    Grauslund, J. G.
    Stokholm, L. S.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2024, 34 (01) : 32 - 33
  • [35] Ranibizumab and aflibercept levels and its impact on vascular endothelial growth factor in human breast milk following intravitreal injection
    Juncal, Verena
    Paracha, Quratulain
    Bamakrid, Motaz
    Francisconi, Carolina
    Farah, Julia Lima
    Kherani, Amin
    Muni, Rajeev
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [36] Polymorphisms of Vascular Endothelial Growth Factor and Retinopathy of Prematurity
    Ali, Aliaa A.
    Hussien, Nouran F.
    Samy, Rania M.
    Al Husseiny, Khalid
    JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS, 2015, 52 (04) : 245 - 253
  • [37] Effects of Intravitreal Aflibercept on Galectin-1 and Vascular Endothelial Growth Factor-A Plasma Levels in Patients with Diabetic Retinopathy
    Waltl, Inga
    Zehetner, Claus
    Seifarth, Christof
    Handle, Florian
    Kieselbach, Gerhard F.
    Angermann, Reinhard
    Kralinger, Martina T.
    CURRENT EYE RESEARCH, 2018, 43 (03) : 368 - 375
  • [38] Serum Concentrations of Bevacizumab (Avastin) and Vascular Endothelial Growth Factor in Infants With Retinopathy of Prematurity
    Sato, Tatsuhiko
    Wada, Kazuko
    Arahori, Hitomi
    Kuno, Noriyuki
    Imoto, Kenji
    Iwahashi-Shima, Chiharu
    Kusaka, Shunji
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2012, 153 (02) : 327 - 333
  • [39] Allergic reaction to intravitreal injection of aflibercept, an anti-vascular endothelial growth factor drug
    Kawakami, Ryuzaburo
    Inoue, Ryo
    Bando, Hajime
    Ikeda, Toshihide
    Emi, Kazuyuki
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [40] Retinal Detachment after Treatment of Retinopathy of Prematurity with Laser versus Intravitreal Anti-Vascular Endothelial Growth Factor
    Barry, Gerard P.
    Yu, Yinxi
    Ying, Gui-Shuang
    Tomlinson, Lauren A.
    Lajoie, Juliann
    Fisher, Marilyn
    Binenbaum, Gil
    OPHTHALMOLOGY, 2021, 128 (08) : 1188 - 1196
12345